Review




Structured Review

Proteintech hadha
Hadha, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 38 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hadha/HADHA+Antibody/pm41872163-137-27-29
Average 94 stars, based on 38 article reviews
hadha - by Bioz Stars, 2026-10
94/100 stars

Images

Related Articles

Incubation:

Article Title: SIRT1 deficiency promotes age-related heart failure through enhancing ferroptosis via GATA4-HADHA-GPX4 axis.
Article Snippet: Proteins were transferred to PVDF membranes (Millipore, Billerica, MA, USA). .. The membranes were then incubated with primary antibodies against TF (1:500, Proteintech, cat#17435-1-AP, RRID: AB_2035023), FTH1 (1:500, Bioss, cat#bs-5907R, RRID: AB_11050926), GPX4 (1:500, Abcam, cat#ab125066, RRID: AB_10973901), HADHA (1:2000, Proteintech, cat#10758-1-AP, RRID: AB_2115593), and SIRT1 (IP, 1:500, Proteintech, cat#60303-1-Ig, RRID: AB_2881417; IB, 1:500, Abcam, cat#ab189494, RRID: AB_2864311), GATA4 (1:500, Proteintech, cat#19530-1-AP, RRID: AB_10642003), and GAPDH (1:10000, Abcam, cat#ab128915, RRID: AB_2747414) at 4°C overnight. .. After washing, the membranes were incubated with anti-IgG horseradish peroxidase-conjugated secondary antibodies (Jackson Immuno Research, West Grove, PA, USA).

Article Title: Very high-dose vitamin D₃ supplementation reduces the expression of genes and proteins engaged in β-oxidation in healthy pigs.
Article Snippet: For the Western blotting, 10 μg of protein samples were separated by 12 % SDS/PAGE gel and transferred with semi-wet transfer onto a polyvinylidene difluoride (PVDF) membrane (Trans-Blot Turbo System, Bio-Rad, USA). .. The membrane was blocked with 3 % BSA (Serva, Germany) in TBS containing 0.1 % Tween-20 (TBS-T) for one h at room temperature and then incubated with primary antibody against LDHB, HADHA, CRP, RGN, IDH1, ASL, ACSL5, ACADM, TPI1, β-tubulin (Proteintech, Germany), or β-actin (Invitrogen, USA) dissolved in blocking buffer, overnight at 4 ◦C. .. The blots were then washed in TBS-T three times and incubated with HRP-labeled secondary antibody (Thermo Scientific, USA) for 1 h at room temperature.

Article Title: SIRT1 deficiency promotes age-related heart failure through enhancing ferroptosis via GATA4-HADHA-GPX4 axis
Article Snippet: Proteins were transferred to PVDF membranes (Millipore, Billerica, MA, USA). .. The membranes were then incubated with primary antibodies against TF (1:500, Proteintech, cat#17435-1-AP, RRID: AB_2035023), FTH1 (1:500, Bioss, cat#bs-5907R, RRID: AB_11050926), GPX4 (1:500, Abcam, cat#ab125066, RRID: AB_10973901), HADHA (1:2000, Proteintech, cat#10758-1-AP, RRID: AB_2115593), and SIRT1 (IP, 1:500, Proteintech, cat#60303-1-Ig, RRID: AB_2881417; IB, 1:500, Abcam, cat#ab189494, RRID: AB_2864311), GATA4 (1:500, Proteintech, cat#19530-1-AP, RRID: AB_10642003), and GAPDH (1:10000, Abcam, cat#ab128915, RRID: AB_2747414) at 4°C overnight. .. After washing, the membranes were incubated with anti-IgG horseradish peroxidase-conjugated secondary antibodies (Jackson Immuno Research, West Grove, PA, USA).

Membrane:

Article Title: Very high-dose vitamin D₃ supplementation reduces the expression of genes and proteins engaged in β-oxidation in healthy pigs.
Article Snippet: For the Western blotting, 10 μg of protein samples were separated by 12 % SDS/PAGE gel and transferred with semi-wet transfer onto a polyvinylidene difluoride (PVDF) membrane (Trans-Blot Turbo System, Bio-Rad, USA). .. The membrane was blocked with 3 % BSA (Serva, Germany) in TBS containing 0.1 % Tween-20 (TBS-T) for one h at room temperature and then incubated with primary antibody against LDHB, HADHA, CRP, RGN, IDH1, ASL, ACSL5, ACADM, TPI1, β-tubulin (Proteintech, Germany), or β-actin (Invitrogen, USA) dissolved in blocking buffer, overnight at 4 ◦C. .. The blots were then washed in TBS-T three times and incubated with HRP-labeled secondary antibody (Thermo Scientific, USA) for 1 h at room temperature.

Blocking Assay:

Article Title: Very high-dose vitamin D₃ supplementation reduces the expression of genes and proteins engaged in β-oxidation in healthy pigs.
Article Snippet: For the Western blotting, 10 μg of protein samples were separated by 12 % SDS/PAGE gel and transferred with semi-wet transfer onto a polyvinylidene difluoride (PVDF) membrane (Trans-Blot Turbo System, Bio-Rad, USA). .. The membrane was blocked with 3 % BSA (Serva, Germany) in TBS containing 0.1 % Tween-20 (TBS-T) for one h at room temperature and then incubated with primary antibody against LDHB, HADHA, CRP, RGN, IDH1, ASL, ACSL5, ACADM, TPI1, β-tubulin (Proteintech, Germany), or β-actin (Invitrogen, USA) dissolved in blocking buffer, overnight at 4 ◦C. .. The blots were then washed in TBS-T three times and incubated with HRP-labeled secondary antibody (Thermo Scientific, USA) for 1 h at room temperature.

Control:

Article Title: Putative Role of Fatty Acid Metabolic Therapy Using Ketogenic Diet and HIF-1α Inhibition in Hepatocellular Carcinoma: Evidence from an In Vitro Study
Article Snippet: .. The primary antibodies used were HIF-1α (1:1000; cat. no. 610959; BD Biosciences, CA, USA), HEL (Hexanoyl Lysine; 1:1000; cat. no. MHL-021P; JaICA, Shizuoka, Japan), cleaved caspase-3 (1:1000; cat. no. 9661; Cell Signaling Technology, Danvers, MA, USA), ACSL1 (acyl-CoA synthetase long-chain family member 1; 1:1000; cat. no. 13989-1-AP; Proteintech, Rosemont, IL, USA), CPT1A (carnitine palmitoyltransferase 1A; 1:1000; cat. no. 12252; Cell Signaling Technology), MCAD (medium-chain acyl-CoA dehydrogenase; 1:1000; cat. no. 55210-1-AP; Proteintech), LCAD (long-chain acyl-CoA dehydrogenase; 1:2000; cat. no. 17442-1-AP; Proteintech), HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha; 1:50,000; cat. no. 10758-1-AP; Proteintech), HADHB (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta; 1:12,000; cat. no. 29091-1-AP; Proteintech), ECHS1 (enoyl-CoA hydratase, short chain 1; 1:20,000; cat. no. 29091-1-AP; Proteintech), BDH1 (3-hydroxybutyrate dehydrogenase type 1; 1:10,000; cat. no. 67448-1-lg; Proteintech), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2; 1:2000; cat. no. 20940; Cell Signaling Technology), HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase; 1:2000; cat. no. ab197022; abcam, Cambridge, UK), MCT4 (monocarboxylate transporter 4; 1:100,000; cat. no. 22787-1-AP; Proteintech), MCT1 (monocarboxylate transporter 1; 1:3000; cat. no. 85680; Cell Signaling Technology), OXCT1 (3-oxoacid CoA-transferase 1; 1:30,000; cat. no. 67836-1-lg; Proteintech), ACAT1 (acetyl-CoA acetyltransferase 1; 1:10,000; cat. no. 44276; Cell Signaling Technology); ACTB (β-actin; 1:10,000, cat. no. AC15; Sigma-Aldrich; Merck KGaA, MO, USA) was used as the internal control. ..

Article Title: Putative Role of Fatty Acid Metabolic Therapy Using Ketogenic Diet and HIF-1α Inhibition in Hepatocellular Carcinoma: Evidence from an In Vitro Study.
Article Snippet: .. The primary antibodies used were HIF-1α (1:1000; cat. no. 610959; BD Biosciences, CA, USA), HEL (Hexanoyl Lysine; 1:1000; cat. no. MHL-021P; JaICA, Shizuoka, Japan), cleaved caspase-3 (1:1000; cat. no. 9661; Cell Signaling Technology, Danvers, MA, USA), ACSL1 (acyl-CoA synthetase long-chain family member 1; 1:1000; cat. no. 13989-1-AP; Proteintech, Rosemont, IL, USA), CPT1A (carnitine palmitoyltransferase 1A; 1:1000; cat. no. 12252; Cell Signaling Technology), MCAD (medium-chain acyl-CoA dehydrogenase; 1:1000; cat. no. 55210-1-AP; Proteintech), LCAD (long-chain acyl-CoA dehydrogenase; 1:2000; cat. no. 17442-1-AP; Proteintech), HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha; 1:50,000; cat. no. 10758-1-AP; Proteintech), HADHB (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta; 1:12,000; cat. no. 29091-1-AP; Proteintech), ECHS1 (enoyl-CoA hydratase, short chain 1; 1:20,000; cat. no. 29091-1-AP; Proteintech), BDH1 (3-hydroxybutyrate dehydrogenase type 1; 1:10,000; cat. no. 67448-1-lg; Proteintech), HMGCS2 (3-hydroxy-3methylglutaryl-CoA synthase 2; 1:2000; cat. no. 20940; Cell Signaling Technology), HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase; 1:2000; cat. no. ab197022; abcam, Cambridge, UK), MCT4 (monocarboxylate transporter 4; 1:100,000; cat. no. 22787-1-AP; Proteintech), MCT1 (monocarboxylate transporter 1; 1:3000; cat. no. 85680; Cell Signaling Technology), OXCT1 (3-oxoacid CoA-transferase 1; 1:30,000; cat. no. 67836-1-lg; Proteintech), ACAT1 (acetyl-CoA acetyltransferase 1; 1:10,000; cat. no. 44276; Cell Signaling Technology); ACTB (β-actin; 1:10,000, cat. no. AC15; Sigma-Aldrich; Merck KGaA, MO, USA) was used as the internal control. ..



Similar Products

85
Thermo Fisher gene exp hadha hs00426191 m1
LYPLAL1 knockout alters the expression of metabolic regulators and mitochondrial β-oxidation processes. A: mRNA levels of transcription factors MLXIPL and PPARα without oleic acid (OA) and with 200 μM OA. B and C: mRNA levels of (B) de novo lipogenesis genes and (C) β-oxidation genes with and without 200 μM OA treatment. D: Representative histograms and relative mean fluorescence intensity (MFI) showing protein levels of major β-oxidation enzymes ACADVL, ACADM, and <t>HADHA</t> without oleic acid and with 200 μM OA. E: Seahorse XF assay for mitochondrial oxygen consumption rate (OCR) in vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. Port A: Etomoxir (4 μM), port B: Oligomycin (1.5 μM), port C: FCCP (0.5 μM), and port D: Rotenone/antimycin A (0.5 μM). F: Maximal oxygen consumption rate (OCR) with vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. LYP KO = LYPLAL1 KO, Eto = Etomoxir. G: Vehicle treated (<1% DMSO) and etomoxir treated (100 μM) HuH-7 and LYPLAL1 KO cells with 200 μM OA. Cells were treated with etomoxir and oleic acid for 24 h. Data represented as mean ± S.E.M. ns: P > 0.05, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.
Gene Exp Hadha Hs00426191 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hadha/Gene+Exp%2E+HADHA%2C+Hs00426191_m1/pmc13090602-67-29--1
Average 85 stars, based on 1 article reviews
gene exp hadha hs00426191 m1 - by Bioz Stars, 2026-10
85/100 stars
  Buy from Supplier

94
ABclonal Biotechnology rabbit anti hydroxyacyl coa dehydrogenase trifunctional multienzyme complex subunit alpha
LYPLAL1 knockout alters the expression of metabolic regulators and mitochondrial β-oxidation processes. A: mRNA levels of transcription factors MLXIPL and PPARα without oleic acid (OA) and with 200 μM OA. B and C: mRNA levels of (B) de novo lipogenesis genes and (C) β-oxidation genes with and without 200 μM OA treatment. D: Representative histograms and relative mean fluorescence intensity (MFI) showing protein levels of major β-oxidation enzymes ACADVL, ACADM, and <t>HADHA</t> without oleic acid and with 200 μM OA. E: Seahorse XF assay for mitochondrial oxygen consumption rate (OCR) in vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. Port A: Etomoxir (4 μM), port B: Oligomycin (1.5 μM), port C: FCCP (0.5 μM), and port D: Rotenone/antimycin A (0.5 μM). F: Maximal oxygen consumption rate (OCR) with vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. LYP KO = LYPLAL1 KO, Eto = Etomoxir. G: Vehicle treated (<1% DMSO) and etomoxir treated (100 μM) HuH-7 and LYPLAL1 KO cells with 200 μM OA. Cells were treated with etomoxir and oleic acid for 24 h. Data represented as mean ± S.E.M. ns: P > 0.05, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.
Rabbit Anti Hydroxyacyl Coa Dehydrogenase Trifunctional Multienzyme Complex Subunit Alpha, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hadha/%5BKO+Validated%5D+HADHA+Rabbit+pAb/pmc13376381-53-10-41
Average 94 stars, based on 1 article reviews
rabbit anti hydroxyacyl coa dehydrogenase trifunctional multienzyme complex subunit alpha - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Proteintech hadha
LYPLAL1 knockout alters the expression of metabolic regulators and mitochondrial β-oxidation processes. A: mRNA levels of transcription factors MLXIPL and PPARα without oleic acid (OA) and with 200 μM OA. B and C: mRNA levels of (B) de novo lipogenesis genes and (C) β-oxidation genes with and without 200 μM OA treatment. D: Representative histograms and relative mean fluorescence intensity (MFI) showing protein levels of major β-oxidation enzymes ACADVL, ACADM, and <t>HADHA</t> without oleic acid and with 200 μM OA. E: Seahorse XF assay for mitochondrial oxygen consumption rate (OCR) in vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. Port A: Etomoxir (4 μM), port B: Oligomycin (1.5 μM), port C: FCCP (0.5 μM), and port D: Rotenone/antimycin A (0.5 μM). F: Maximal oxygen consumption rate (OCR) with vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. LYP KO = LYPLAL1 KO, Eto = Etomoxir. G: Vehicle treated (<1% DMSO) and etomoxir treated (100 μM) HuH-7 and LYPLAL1 KO cells with 200 μM OA. Cells were treated with etomoxir and oleic acid for 24 h. Data represented as mean ± S.E.M. ns: P > 0.05, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.
Hadha, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hadha/HADHA+Antibody/pm41872163-137-27-29
Average 94 stars, based on 1 article reviews
hadha - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Proteintech 1 ap
LYPLAL1 knockout alters the expression of metabolic regulators and mitochondrial β-oxidation processes. A: mRNA levels of transcription factors MLXIPL and PPARα without oleic acid (OA) and with 200 μM OA. B and C: mRNA levels of (B) de novo lipogenesis genes and (C) β-oxidation genes with and without 200 μM OA treatment. D: Representative histograms and relative mean fluorescence intensity (MFI) showing protein levels of major β-oxidation enzymes ACADVL, ACADM, and <t>HADHA</t> without oleic acid and with 200 μM OA. E: Seahorse XF assay for mitochondrial oxygen consumption rate (OCR) in vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. Port A: Etomoxir (4 μM), port B: Oligomycin (1.5 μM), port C: FCCP (0.5 μM), and port D: Rotenone/antimycin A (0.5 μM). F: Maximal oxygen consumption rate (OCR) with vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. LYP KO = LYPLAL1 KO, Eto = Etomoxir. G: Vehicle treated (<1% DMSO) and etomoxir treated (100 μM) HuH-7 and LYPLAL1 KO cells with 200 μM OA. Cells were treated with etomoxir and oleic acid for 24 h. Data represented as mean ± S.E.M. ns: P > 0.05, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.
1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hadha/HADHA+Antibody/pm41806834-637-80-78
Average 94 stars, based on 1 article reviews
1 ap - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse monoclonal anti hadha
LYPLAL1 knockout alters the expression of metabolic regulators and mitochondrial β-oxidation processes. A: mRNA levels of transcription factors MLXIPL and PPARα without oleic acid (OA) and with 200 μM OA. B and C: mRNA levels of (B) de novo lipogenesis genes and (C) β-oxidation genes with and without 200 μM OA treatment. D: Representative histograms and relative mean fluorescence intensity (MFI) showing protein levels of major β-oxidation enzymes ACADVL, ACADM, and <t>HADHA</t> without oleic acid and with 200 μM OA. E: Seahorse XF assay for mitochondrial oxygen consumption rate (OCR) in vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. Port A: Etomoxir (4 μM), port B: Oligomycin (1.5 μM), port C: FCCP (0.5 μM), and port D: Rotenone/antimycin A (0.5 μM). F: Maximal oxygen consumption rate (OCR) with vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. LYP KO = LYPLAL1 KO, Eto = Etomoxir. G: Vehicle treated (<1% DMSO) and etomoxir treated (100 μM) HuH-7 and LYPLAL1 KO cells with 200 μM OA. Cells were treated with etomoxir and oleic acid for 24 h. Data represented as mean ± S.E.M. ns: P > 0.05, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.
Mouse Monoclonal Anti Hadha, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hadha/DRP1+Antibody/pmc13002879-182-86-90
Average 96 stars, based on 1 article reviews
mouse monoclonal anti hadha - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse monoclonal anti parkin
LYPLAL1 knockout alters the expression of metabolic regulators and mitochondrial β-oxidation processes. A: mRNA levels of transcription factors MLXIPL and PPARα without oleic acid (OA) and with 200 μM OA. B and C: mRNA levels of (B) de novo lipogenesis genes and (C) β-oxidation genes with and without 200 μM OA treatment. D: Representative histograms and relative mean fluorescence intensity (MFI) showing protein levels of major β-oxidation enzymes ACADVL, ACADM, and <t>HADHA</t> without oleic acid and with 200 μM OA. E: Seahorse XF assay for mitochondrial oxygen consumption rate (OCR) in vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. Port A: Etomoxir (4 μM), port B: Oligomycin (1.5 μM), port C: FCCP (0.5 μM), and port D: Rotenone/antimycin A (0.5 μM). F: Maximal oxygen consumption rate (OCR) with vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. LYP KO = LYPLAL1 KO, Eto = Etomoxir. G: Vehicle treated (<1% DMSO) and etomoxir treated (100 μM) HuH-7 and LYPLAL1 KO cells with 200 μM OA. Cells were treated with etomoxir and oleic acid for 24 h. Data represented as mean ± S.E.M. ns: P > 0.05, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.
Mouse Monoclonal Anti Parkin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hadha/HADHA+Antibody/pmc13002879-182-100-104
Average 93 stars, based on 1 article reviews
mouse monoclonal anti parkin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


LYPLAL1 knockout alters the expression of metabolic regulators and mitochondrial β-oxidation processes. A: mRNA levels of transcription factors MLXIPL and PPARα without oleic acid (OA) and with 200 μM OA. B and C: mRNA levels of (B) de novo lipogenesis genes and (C) β-oxidation genes with and without 200 μM OA treatment. D: Representative histograms and relative mean fluorescence intensity (MFI) showing protein levels of major β-oxidation enzymes ACADVL, ACADM, and HADHA without oleic acid and with 200 μM OA. E: Seahorse XF assay for mitochondrial oxygen consumption rate (OCR) in vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. Port A: Etomoxir (4 μM), port B: Oligomycin (1.5 μM), port C: FCCP (0.5 μM), and port D: Rotenone/antimycin A (0.5 μM). F: Maximal oxygen consumption rate (OCR) with vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. LYP KO = LYPLAL1 KO, Eto = Etomoxir. G: Vehicle treated (<1% DMSO) and etomoxir treated (100 μM) HuH-7 and LYPLAL1 KO cells with 200 μM OA. Cells were treated with etomoxir and oleic acid for 24 h. Data represented as mean ± S.E.M. ns: P > 0.05, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.

Journal: Journal of Lipid Research

Article Title: LYPLAL1 rare loss-of-function variants in humans and deletion in human hepatoma cells protect against MASLD

doi: 10.1016/j.jlr.2026.101013

Figure Lengend Snippet: LYPLAL1 knockout alters the expression of metabolic regulators and mitochondrial β-oxidation processes. A: mRNA levels of transcription factors MLXIPL and PPARα without oleic acid (OA) and with 200 μM OA. B and C: mRNA levels of (B) de novo lipogenesis genes and (C) β-oxidation genes with and without 200 μM OA treatment. D: Representative histograms and relative mean fluorescence intensity (MFI) showing protein levels of major β-oxidation enzymes ACADVL, ACADM, and HADHA without oleic acid and with 200 μM OA. E: Seahorse XF assay for mitochondrial oxygen consumption rate (OCR) in vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. Port A: Etomoxir (4 μM), port B: Oligomycin (1.5 μM), port C: FCCP (0.5 μM), and port D: Rotenone/antimycin A (0.5 μM). F: Maximal oxygen consumption rate (OCR) with vehicle or etomoxir treated HuH-7 and LYPLAL1 KO cells without oleic acid and with 200 μM OA. LYP KO = LYPLAL1 KO, Eto = Etomoxir. G: Vehicle treated (<1% DMSO) and etomoxir treated (100 μM) HuH-7 and LYPLAL1 KO cells with 200 μM OA. Cells were treated with etomoxir and oleic acid for 24 h. Data represented as mean ± S.E.M. ns: P > 0.05, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.

Article Snippet: Probes used: GAPDH (Hs02786624_g1), ELF1 (Hs01111177_m1), MLXIPL (Hs00975714_m1), PPARα (Hs00947536_m1), ACACA (Hs01046047_m1), ACLY (Hs00982738_m1), FASN (Hs01005622_m1), SCD (Hs01682761_m1), CPT1A (Hs00912671_m1), ACADL (Hs00155630_m1), ACADM (Hs00936584_m1), ACADVL (Hs00825606_g1), EHHADH (Hs00157347_m1), HADHA (Hs00426191_m1), CD36 (Hs00354519_m1), and FABP1 (Hs00155026_m1).

Techniques: Knock-Out, Expressing, Fluorescence, XF Assay